← 返回產品資料庫

錄秘帕斯G 癌抗原19-9-N檢驗試劑

🩺 醫材

Lumipulse G CA19-9 -N

衛署醫器輸字第021667號

醫材分類

2 等級
  • C.6010腫瘤相關抗原免疫試驗系統

醫器規格

3 × 14 Tests (42 Tests/Kit)

限制項目

輸 入

適應症

測定人類血清或血漿中之CA19-9

醫材資訊

主成分
1. Antibody-Coated Particle Solution (Liquid when used, 250μL / Immunoreaction Cartridge)\n Contains 150 μg/mL anti-CA19-9 monoclonal antibody (mouse)-coated particles, protein stabilizers (bovine and mouse) and chemical stabilizers in 0.15 M sodium chloride/Tris buffer. This solution contains gelatin and turns into gel at 15 °C or lower. Preservative: sodium azide.\n2. Enzyme-Labeled Antibody Solution (Liquid, 350μL / Immunoreaction Cartridge)\n Contain 0.5 μg/mL alkaline phosphatase (ALP: calf)-labeled anti-CA19-9 monoclonal antibody (mouse), protein stabilizers (bovine, calf and mouse) and chemical stabilizers in 0.05 M sodium chloride/Bis-Tris buffer. Preservative\n
製造商
Fujirebio Inc. Sagamihara Facility
製造國
JP
申請商
育聖企業有限公司
有效日期
2030/10/27
發證日期
2010/10/27

供應藥局

目前尚無登錄供應此品項的藥局資料。